πŸ‡ΊπŸ‡Έ FDA
Patent

US 8785168

Formulations for lysosomal enzymes

granted A61KA61K38/30A61K38/47

Quick answer

US patent 8785168 (Formulations for lysosomal enzymes) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN PHARMACEUTICAL INC.
Grant date
Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/30, A61K38/47, A61K47/10, A61K47/26